Carsten Schmelter
8PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 29, 2023
Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A).Carsten Schmelter, Kristian Nzogang Fomo, Alina Brueck
|Jan 21, 2023
Lectin-Based Affinity Enrichment and Characterization of N-Glycoproteins from Human Tear Film by Mass Spectrometry.Carsten Schmelter, Alina Brueck, Natarajan Perumal
|Nov 11, 2022
Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma.Henrik Tonner, Selina Hunn, Nadine Auler
|Apr 23, 2022
A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma.Henrik Tonner, Selina Hunn, Nadine Auler
|Aug 27, 2021
Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications.Vanessa M Beutgen, Carsten Schmelter, Norbert Pfeiffer
|Aug 27, 2021
Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues.Carsten Schmelter, Kristian Nzogang Fomo, Natarajan Perumal
Pageof 2
